Press Release: ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Rocket (RCKT) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Rocket securities between February 27, 2025 to May 26, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion…
ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment Healthcare” or the “Company”), an award-winning Medicare Advantage (MA) company, today announced the pricing of its previously announced underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P (the “Selling Stockholder”). The underwriter sold…
New York, New York, March 02, 2026 (GLOBE NEWSWIRE) -- As the digital landscape undergoes a fundamental shift, two pillars of the decentralized movement are demonstrating that the future of the web lies in a return to its foundational principles. CryptoMondays, the world’s largest in-real-life (IRL) community for Web3 enthusiasts, and Swarm, the decentralized backbone…
BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against uniQure N.V. (Nasdaq: QURE) and certain of its executives. Investors who have lost money in their uniQure N.V.investment should contact the firm to learn more about how they might recover those losses. For more details,…
NEW YORK, N.Y., March 02, 2026 (GLOBE NEWSWIRE) -- LumeFlow AI, the one-stop AI content generation platform, has expanded its all-in-one dashboard with the latest next-gen video and image models: Seedance 2.0 for video and Nano Banana 2 for high-fidelity imagery. This major update is accompanied by the release of Motion Mimic and Lip Sync,…
Company Announcement COPENHAGEN, Denmark; March 2, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a maximum aggregate total value of DKK 725 million to honor our commitments under the Restricted Stock Unit program.
